FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| US Specialty Formulations LLC | 079181064 | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; 20 mg/1 mL | 2022-1 | valid | 2026-10-13 | |
| US Specialty Formulations LLC | 079181064 | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; 20 mg/1 mL | 2021-2 | valid | 2026-10-13 | |
| US Specialty Formulations LLC | 079181064 | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; 20 mg/1 mL | 2021-1 | valid | 2026-10-13 | |
| US Specialty Formulations LLC | 079181064 | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; 20 mg/1 mL | 2020-2 | valid | 2026-10-13 | |
| US Specialty Formulations LLC | 079181064 | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; 20 mg/1 mL | 2020-1 | valid | 2026-10-13 |